GXLV.L vs. GNOM.L
GXLV.L (SPDR S&P US Health Care Select Sector UCITS ETF) and GNOM.L (Global X Genomics & Biotechnology UCITS ETF USD (Acc)) are both exchange-traded funds - GXLV.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD, while GNOM.L is a Genomics fund tracking the Solactive Genomics v2 Index. Both are passively managed. Over the past 3 years, GXLV.L returned 7.25%/yr vs 2.60%/yr for GNOM.L. At a 0.37 correlation, their price movements are largely independent. GXLV.L charges 0.15%/yr vs 0.50%/yr for GNOM.L.
Performance
GXLV.L vs. GNOM.L - Performance Comparison
Loading charts...
Different Trading Currencies
GXLV.L is traded in GBP, while GNOM.L is traded in USD. To make them comparable, the GNOM.L values have been converted to GBP using the latest available exchange rates.
Returns By Period
In the year-to-date period, GXLV.L achieves a 4.49% return, which is significantly lower than GNOM.L's 19.53% return.
GXLV.L
- 1D
- 0.00%
- 1M
- 5.91%
- 6M
- 3.34%
- YTD
- 4.49%
- 1Y
- 22.45%
- 3Y*
- 7.25%
- 5Y*
- -0.06%
- 10Y*
- 6.42%
GNOM.L
- 1D
- -1.55%
- 1M
- 3.78%
- 6M
- 12.47%
- YTD
- 19.53%
- 1Y
- 57.17%
- 3Y*
- 2.60%
- 5Y*
- —
- 10Y*
- —
GXLV.L vs. GNOM.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GXLV.L SPDR S&P US Health Care Select Sector UCITS ETF | 4.49% | 7.08% | 3.73% | -3.91% | -18.87% | 5.78% |
GNOM.L Global X Genomics & Biotechnology UCITS ETF USD (Acc) | 19.53% | 10.80% | -16.55% | -10.48% | -29.74% | -8.05% |
Correlation
The correlation between GXLV.L and GNOM.L is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.42 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.38 |
Correlation (All Time) Calculated using the full available price history since Nov 2, 2021 | 0.37 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GXLV.L vs. GNOM.L — Risk / Return Rank
GXLV.L
GNOM.L
GXLV.L vs. GNOM.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) and Global X Genomics & Biotechnology UCITS ETF USD (Acc) (GNOM.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GXLV.L | GNOM.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.48 | ||
| Sortino ratioReturn per unit of downside risk | -0.49 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.32 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 1.96 | 3.35 | -1.39 |
| Martin ratioReturn relative to average drawdown | 4.85 | 8.35 | -3.50 |
Loading charts...
Drawdowns
GXLV.L vs. GNOM.L - Drawdown Comparison
The maximum GXLV.L drawdown since its inception was -31.32%, smaller than the maximum GNOM.L drawdown of -67.55%. Use the drawdown chart below to compare losses from any high point for GXLV.L and GNOM.L.
Loading charts...
Drawdown Indicators
| GXLV.L | GNOM.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -31.32% | -67.55% | +36.23% |
Max Drawdown (1Y)Largest decline over 1 year | -11.51% | -16.99% | +5.48% |
Max Drawdown (3Y)Largest decline over 3 years | -19.59% | -45.06% | +25.47% |
Max Drawdown (5Y)Largest decline over 5 years | -31.32% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -31.32% | — | — |
Current DrawdownCurrent decline from peak | -9.88% | -38.02% | +28.14% |
Average DrawdownAverage peak-to-trough decline | -10.51% | -43.90% | +33.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.64% | 6.82% | -2.18% |
Volatility
GXLV.L vs. GNOM.L - Volatility Comparison
The current volatility for SPDR S&P US Health Care Select Sector UCITS ETF (GXLV.L) is 5.69%, while Global X Genomics & Biotechnology UCITS ETF USD (Acc) (GNOM.L) has a volatility of 8.65%. This indicates that GXLV.L experiences smaller price fluctuations and is considered to be less risky than GNOM.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GXLV.L | GNOM.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.69% | 8.65% | -2.96% |
Volatility (6M)Calculated over the trailing 6-month period | 11.26% | 21.54% | -10.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.37% | 29.25% | -13.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.80% | 32.06% | -14.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.96% | 32.06% | -14.10% |
GXLV.L vs. GNOM.L - Expense Ratio Comparison
GXLV.L has a 0.15% expense ratio, which is lower than GNOM.L's 0.50% expense ratio.
Dividends
GXLV.L vs. GNOM.L - Dividend Comparison
Neither GXLV.L nor GNOM.L has paid dividends to shareholders.
Frequently Asked Questions
GXLV.L and GNOM.L have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GXLV.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GXLV.L is cheaper with a 0.15% expense ratio, compared with 0.50% for GNOM.L.
GXLV.L is categorized as Health & Biotech Equities, while GNOM.L is Genomics. GXLV.L tracks MSCI World/Health Care NR USD, while GNOM.L tracks Solactive Genomics v2 Index. They also come from different issuers: State Street and Global X. Their fees differ too: 0.15% for GXLV.L and 0.50% for GNOM.L.
Find the right allocation for GXLV.L and GNOM.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer